Plain-English translation of NCT07197632 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether intraoperative MRI—a special imaging machine that works during surgery—helps surgeons better locate and remove brain metastases (tumors that have spread to the brain from elsewhere in the body). Some participants will have surgery with this live imaging technology, while others will have standard surgery without it. The goal is to see if this advanced imaging improves how much tumor is removed and reduces the need for additional treatments.
Brain metastasis surgery is challenging because tumors can be hard to see and remove completely. While this imaging technology promises to give surgeons a clearer view during the operation, it also takes longer and might carry risks. This study is designed to carefully measure whether the benefits outweigh these drawbacks.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo brain surgery for your metastases. Your surgeon will randomly assign you to either standard surgery or surgery that includes the advanced imaging technology during the procedure. After surgery, you will be monitored and followed up to evaluate how well the tumor was removed and how you recover. The study will compare outcomes between the two groups to determine whether the advanced imaging improves surgical results.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Germany
Technical University of Munich
Enrollment target
~154 participants
Started
January 2025
Primary completion
January 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Maria Goldberg
Technical University of Munich
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.